Cellebrite DI Ltd (NASDAQ:CLBT) currently has a daily average trading volume of 1.55M but it saw 1312824 shares traded in last market. With a market cap of 3.53B USD, the company’s current market price of $17.01 came falling about -2.24 while comparing to the previous closing price of $17.40. In past 52 weeks, the stock remained buoying in the range of price level as high as $17.48 and as low as $6.36. In the recent trading on the day, stock has struck highest price mark of $16.905 while lowest mark touched by it was $17.46.
Taking a look at 20-day trading activity of Cellebrite DI Ltd (CLBT) gives us an average price of $14.90, while its current price level is -2.66% below from 52-week high level whereas it is 167.24% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $13.42 while that of 200 days or SMA-200 reads an average of $10.92. A closer look into the stock’s movement over the week reveals that its volatility is standing at 3.20% during that period while stretching the period over a month that increases to 4.48%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 71.01 which implies that the stock is in overbought territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Needham which reiterated the stock as “Buy” in its note to investors issued on March 28, 2024, recommending a price target of between $13 and $13.50 for it. BofA Securities issued its recommendations for the stock as it upgraded the price target for the stock in the range of between $9 and $12.
Over the week, CLBT’s stock price is moving 2.35% up while it is 24.43% when we observe its performance for the past one month. Year-to-date it is 96.42% up and over the past year, the stock is showing an upside performance of 120.91%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of 0.1 beat the consensus estimate of 0.05 for the same. The company is expected to be releasing its next quarterly report on 2024-Nov-11, for which analysts forecasted an EPS of 0.09 while estimate for next year EPS is 0.41. In next quarter, company is expected to be making quarterly sales of $106.96M as analysts are expecting the sales for current fiscal year at $394.23M and seeing the company making $461.51M in sales next year. Moreover, analysts are in estimates of $102.06M for current-quarter revenue.
Currently, Cellebrite DI Ltd’s total number of outstanding shares is 203.23M with 48.68% of that held by the insiders while 50.22% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -1768.51%. It has a 55.85 of forward P/E ratio. Stock’s beta reads 1.52. Stock has a price to sale or P/S ratio amounts to 9.74. Its return on asset (ROA) is -21.03% on average.
